This article originally appeared on Inside Climate News , a nonprofit, non-partisan news organization that covers climate, energy, and the environment. Sign up for their newsletter here .

Sen. Susan Collins (R-Maine) kicked off a Wednesday hearing criticizing ​​the Trump administration for cutting science funding, firing federal scientists, and triggering policy uncertainties that she said threaten to undermine the foundation for America’s global leadership.

Collins, chair of the Senate Appropriations Committee, said the administration’s abrupt cancellation of grants and laying off scientists has little or no justification. “These actions put our leadership in biomedical innovation at real risk and must be reversed,” she said.

Read full article

Comments

This article originally appeared on Inside Climate News , a nonprofit, non-partisan news organization that covers climate, energy, and the environment. Sign up for their newsletter here .

Sen. Susan Collins (R-Maine) kicked off a Wednesday hearing criticizing ​​the Trump administration for cutting science funding, firing federal scientists, and triggering policy uncertainties that she said threaten to undermine the foundation for America’s global leadership.

Collins, chair of the Senate Appropriations Committee, said the administration’s abrupt cancellation of grants and laying off scientists has little or no justification. “These actions put our leadership in biomedical innovation at real risk and must be reversed,” she said.

Read full article

Comments

This article originally appeared on Inside Climate News , a nonprofit, non-partisan news organization that covers climate, energy, and the environment. Sign up for their newsletter here .

Sen. Susan Collins (R-Maine) kicked off a Wednesday hearing criticizing ​​the Trump administration for cutting science funding, firing federal scientists, and triggering policy uncertainties that she said threaten to undermine the foundation for America’s global leadership.

Collins, chair of the Senate Appropriations Committee, said the administration’s abrupt cancellation of grants and laying off scientists has little or no justification. “These actions put our leadership in biomedical innovation at real risk and must be reversed,” she said.

Read full article

Comments